Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Shares of Apple and Dell Technologies rise sharply after the Trump administration exempts smartphones, computers, memory ...

The performance gap between high- and low-liquidity stocks has remained surprisingly stable despite recent market turbulence ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

Earnings season kicks off in earnest with big banks continuing to report along with Netflix.

The Wall Street bank posted better-than-expected results, boosted by a surge in equities trading in the first quarter, which ...

Pfizer has ended development of danuglipron, an oral GLP-1 drug for weight management, citing clinical data and regulatory input.

Apple (NASDAQ: AAPL) stock gained 5.8%, Nvidia (NASDAQ: NVDA) rose 3.1%, and Dell Technologies (NYSE: DELL) gained 5.9% as these tech giants benefited from the pause in electronics tariffs.

The Dow Jones Industrial Average added 312.08 points, or 0.78%, to close at 40,524.79. The Nasdaq Composite rose 0.64% to end ...